Oral VPA for adRP worse than placebo

A clinical trial shows Oral Valproic Acid (VPA) used to treat vision loss in patients with autosomal dominant retinitis pigmentosa (adRP) is more detrimental...

New corneal “bandage"

A new therapeutic contact lens that acts as a bandage for eye surface injuries could speed up healing of previously difficult-to-treat corneal wounds.Researcher...

RANZCO apologises, pledges Indigenous commitment

The Royal Australian and New Zealand College of Ophthalmologists (RANZO) has apologised “unreservedly” to Australian Indigenous ophthalmologist Dr Kristopher...

Corneal patch injects drugs

Researchers working on improving delivery methods for ocular drugs have developed a tiny eye patch with dissolving microneedles, which can easily and comfortably...

CLs show drug delivery

Scientists have developed a drug-delivering contact lens (CL) that changes colour as medicines are released to help eye doctors and patients see whether...

Prof Sankaridurg to Head ‘Global Myopia Centre’

Leading international myopia researcher, Professor Padmaja Sankaridurg has been appointed Head of the ‘Global Myopia Centre’ by the Brien Holden Vision...

FDA warns against Raindrop inlay

The US Federal Drug Administration (FDA) has issued a safety communication warning eye care providers and patients about the Raindrop Near Vision Inlay...

Ozurdex batches recalled in NZ

Allergan New Zealand has issued an urgent recall for three batches of its Ozurdex (Dexamethasone) 700 microgram Intraocular Implant. A recall has not yet...

Bottom Banner Advert